Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series) - Image 1

£95.60

CRC Press Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)

Name: Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)
Brand: CRC Press
Price: 95.6 GBP
Availability: InStock

Pharmacy - Dispensing

Price History & Forecast

Last 43 days • 43 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 43 days • 1 price levels

Days at Price

Price Analysis

Most common price: £96 (43 days, 100.0%)

Price range: £96 - £96

Price levels: 1 different prices over 43 days

Description

Product Description Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies. Review "Thus, the book Biosimilar Clinical Development contains five chapters discussing general issues involving biosimilars. The remaining six chapters present statistical methods, many of which are new, and their applications in bioequivalence and biosimilarity studies; they are really research papers. . . It will appeal to readers interested in biosimilars and especially in their statistical assessments." ~ Laszlo Endrenyi, University of Toronto “The book is edited by a team of renowned experts from both statistics and biosimilar clinical development. It contains 11 chapters, covering not only statistical issues but also pre-clinical and clinical development issues not regularly discussed on this kind of book, as well as references to regulatory considerations of upmost importance for statisticians working in the strongly regulated environment of clinical development . . . I strongly recommend the reading of this book. In my opinion, the book should be a must-have reading for professionals who work regularly with biosimilars and want to have an overview of state-of-the art methods for 'hot-topics' in the analysis and planning of clinical trials for this purpose.”~David Manteigas About the Author Dr. Kerry B. Barker is the Vice-President and Head of Early Oncology Research Statistics at Pfizer, Dr. Sandeep Menon is the Vice-President and Head of Biostatistics Research and Consulting Center at Pfizer , Dr. Ralph D’Agostino is a professor of Mathematics and Statistics at Boston University, Dr. Siyan Xu is a senior principal biostatistician at Novartis and Dr.Bo Jin is the Director of Biostatistics in Early Oncology Research at Pfizer. All have been involved with biosimilars clinical development across all regions of the world.

Product Specifications

Brand: CRC Press
Format: Hardcover
ASIN: 1482231697
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 22 June 2016
Listed Since: 15 April 2015

Barcode

No barcode data available

CRC Press Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Methodologies in Biosimilar Product Development (Chapman & Hall/CRC Biostatistics Series)

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Analytical Similarity Assessment in Biosimilar Product Development

Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)

Biosimilars Development Strategies: Fast to Market Approaches

Clinical Trial Biostatistics and Biopharmaceutical Applications

CRC Press Statistical Approaches in Oncology Clinical Development

Statistical Approaches in Oncology Clinical Development: Current Paradigm and Methodological Advancement (Chapman & Hall/CRC Biostatistics Series)

Encyclopedia of Biopharmaceutical Statistics - Four Volume Set

Biologics and Biosimilars: Drug Discovery and Clinical Applications

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Case Studies in Innovative Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Biomarker Analysis in Clinical Trials with R (Chapman & Hall/CRC Biostatistics Series)

Biomarker Analysis in Clinical Trials with R (Chapman & Hall/CRC Biostatistics Series)

Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set

Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Clinical and Statistical Considerations in Personalized Medicine (Chapman & Hall/CRC Biostatistics)

Statistical Methods in Drug Combination Studies: 69 (Chapman & Hall/CRC Biostatistics Series)

Innovative Methods for Rare Disease Drug Development (Chapman & Hall/CRC Biostatistics Series)

Bayesian Applications in Pharmaceutical Development (Chapman & Hall/CRC Biostatistics Series)

Clinical and Statistical Considerations in Personalized Medicine (Chapman & Hall/Crc Biostatistics)

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

Biosimilars and Interchangeable Biologics: Tactical Elements

Phase II Clinical Development of New Drugs (ICSA Book Series in Statistics)